Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?

Gut
Bruce E Sands

Abstract

Immunosuppressive drugs have become a mainstay of therapy for the inflammatory bowel diseases. Although robust evidence exists in support of the use of these drugs in Crohn's disease, a close evaluation of the available data in ulcerative colitis reveals a much weaker evidence base. In particular, randomised controlled trials of azathioprine, the most commonly used immunosuppressive agent, do not provide rich evidence of efficacy whereas observational cohorts suggest this agent is effective, particularly in patients with relapsing disease who require corticosteroids. Ciclosporin is also effective in the most refractory cases but its efficacy needs to be carefully weighed against the possibility of rare but life threatening complications. Although the evidence base in support of immunosuppressive drugs in ulcerative colitis is not as strong as in Crohn's disease, these agents clearly have a role in the treatment of this disease.

References

Jul 4, 1992·BMJ : British Medical Journal·A B HawthorneJ E Lennard-Jones
Jun 1, 1990·The American Journal of Gastroenterology·D J Adler, B I Korelitz
May 1, 1990·Diseases of the Colon and Rectum·A J LoboA T Axon
Jun 1, 1990·Journal of Clinical Gastroenterology·A H SteinhartE J Prokipchuk
Dec 14, 1974·British Medical Journal·D P Jewell, S C Truelove
May 1, 1982·British Medical Journal·A P Kirk, J E Lennard-Jones
Feb 2, 1995·The New England Journal of Medicine·B G FeaganM Hopkins
Jun 30, 1994·The New England Journal of Medicine·S LichtigerS Hanauer
Jul 1, 1997·Journal of Clinical Gastroenterology·S ArdizzoneF Molteni
Jun 10, 1998·European Journal of Gastroenterology & Hepatology·G M HydeD P Jewell
Nov 3, 1998·Alimentary Pharmacology & Therapeutics·W A StackC J Hawkey
Jan 16, 1999·Journal of Pediatric Gastroenterology and Nutrition·H A KaderR N Baldassano
Jun 11, 1999·The American Journal of Gastroenterology·R D CohenS B Hanauer
May 8, 2002·Journal of Gastroenterology·Ajit SoodVineeta Malhotra
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group
Feb 27, 2004·The New England Journal of Medicine·Bruce E SandsSander J van Deventer
Feb 16, 2005·Alimentary Pharmacology & Therapeutics·J R F CummingsD P Jewell

❮ Previous
Next ❯

Citations

Jan 9, 2007·Inflammatory Bowel Diseases·Alexander SwidsinskiYvonne Dörffel
Aug 26, 2009·Inflammatory Bowel Diseases·Liliana Andrade ChebliJulio Maria Fonseca Chebli
Sep 16, 2010·Inflammatory Bowel Diseases·Konstantinos OikonomouSpiros Potamianos
Jun 17, 2011·Nephron. Clinical Practice·Konstantinos A OikonomouSpyros P Potamianos
May 1, 2010·Therapeutic Advances in Chronic Disease·Fernando Bermejo, Javier P Gisbert
Aug 6, 2008·World Journal of Gastroenterology : WJG·Gudrun Scheving ThorsteinssonThomas H Casswall
Dec 22, 2010·Journal of Crohn's & Colitis·Manuel Barreiro-de AcostaJ Enrique Dominguez-Muñoz
Dec 7, 2010·Journal of Gastroenterology·Makoto NaganumaMamoru Watanabe
May 4, 2013·Expert Review of Gastroenterology & Hepatology·Makoto NaganumaToshifumi Hibi
Jul 29, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Giovanni C ActisAnna Sapino
Apr 28, 2009·Alimentary Pharmacology & Therapeutics·J P GisbertF Gomollón
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·G Bianchi PorroS Ardizzone
Nov 1, 2007·Acta Paediatrica·L J HowarthR M Beattie
Mar 6, 2012·The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi·Chang Hwan ChoiUNKNOWN IBD Study Group of the Korean Association for the Study of Intestinal Diseases
Apr 21, 2016·Expert Opinion on Drug Metabolism & Toxicology·Leon P McLean, Raymond K Cross
Nov 16, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Reiji AokiYoshiharu Takayama
Jan 14, 2010·The American Journal of Gastroenterology·Asher KornbluthUNKNOWN Practice Parameters Committee of the American College of Gastroenterology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.